Medpace Holdings (MEDP) Gross Profit Growth (1y) (2016 - 2026)
Medpace Holdings (MEDP) Gross Profit Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 9.56% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 2.50% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 12.14% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 14.32% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 8.47% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 119.42% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 10.79% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 12.13% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 8.91% |
| 10 | Medpace Holdings | 16.56 Bn | 16.06 Bn | 201.64 Mn | 12.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.01% |
| Mar 31, 2026 | 10.08% |
| Dec 31, 2025 | 15.14% |
| Sep 30, 2025 | 16.53% |
| Jun 30, 2025 | 17.01% |
| Mar 31, 2025 | 14.96% |
| Dec 31, 2024 | 30.34% |
| Sep 30, 2024 | 26.89% |
| Jun 30, 2024 | 23.75% |
| Mar 31, 2024 | 19.17% |
| Dec 31, 2023 | 18.21% |
| Sep 30, 2023 | 11.89% |
| Jun 30, 2023 | 25.58% |
| Mar 31, 2023 | 31.93% |
| Dec 31, 2022 | 31.54% |
| Sep 30, 2022 | 36.67% |
| Jun 30, 2022 | 32.61% |
| Mar 31, 2022 | 25.82% |
| Dec 31, 2021 | 6.19% |
| Sep 30, 2021 | 17.44% |